Suppr超能文献

吡喃酮类化合物在药物发现中的研究进展:近期进展

Pyridones in drug discovery: Recent advances.

机构信息

Oncology R&D, AstraZeneca R&D, Waltham, MA 02451, United States.

AstraZeneca, DMPK, Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, United Kingdom.

出版信息

Bioorg Med Chem Lett. 2021 Apr 15;38:127849. doi: 10.1016/j.bmcl.2021.127849. Epub 2021 Feb 18.

Abstract

Pyridones have been utilized as privileged scaffolds in drug discovery. Some of the important roles where this class of heterocycles have found utility in medicinal chemistry include the ability to 1) serve both as a hydrogen bond acceptor and/or a donor; 2) act as a bioisostere for amides, phenyls, pyridines and other nitrogen- or oxygen-containing heterocycles; and 3) impact a target drug molecule's lipophilicity, aqueous solubility and metabolic stability. Detailed discussions of recent advances in their utilization as nonpeptidic mimics and as kinase hinge binding motifs are included. Selected literature examples published from the past twenty years where pyridones have been employed as bioisosteres for phenyls, pyridines, pyridine N-oxides and phenol rings are provided. In addition, this review summarizes the current understanding of possible reactive metabolites related to the pyridone structure.

摘要

吡咯酮类化合物在药物研发中被用作优势骨架。这类杂环在药物化学中有许多重要的用途,包括:1)既能充当氢键受体,又能充当氢键供体;2)作为酰胺、苯基、吡啶和其他含氮或含氧杂环的生物等排体;3)影响靶标药物分子的亲脂性、水溶解度和代谢稳定性。本文详细讨论了将吡咯酮类化合物用作非肽模拟物和作为激酶铰链结合基序的最新进展。本文还提供了过去二十年来将吡咯酮类化合物用作苯基、吡啶、吡啶 N-氧化物和苯酚环的生物等排体的文献实例。此外,本文综述了与吡咯酮结构相关的可能反应性代谢物的现有认识。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验